Alembic Pharmaceuticals Limited (NSE:APLLTD) — Market Cap & Net Worth

$1.59 Billion USD · Rs146.58 Billion INR · Rank #7157

Market Cap & Net Worth: Alembic Pharmaceuticals Limited (APLLTD)

Alembic Pharmaceuticals Limited (NSE:APLLTD) has a market capitalization of $1.59 Billion (Rs146.58 Billion) as of June 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #7157 globally and #333 in its home market, demonstrating a 0.03% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alembic Pharmaceuticals Limited's stock price Rs745.70 by its total outstanding shares 196563124 (196.56 Million). Review Alembic Pharmaceuticals Limited debt and liabilities to assess the company's total debt and financial obligations.

Alembic Pharmaceuticals Limited Market Cap History: 2015 to 2026

Alembic Pharmaceuticals Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.35 Billion to $1.59 Billion (1.19% CAGR).

Index Memberships

Alembic Pharmaceuticals Limited is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.11 Trillion	0.05%	#287 of 500
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.14 Trillion	0.14%	#198 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.05%	#289 of 750
NIFTY SMALLCAP 250 NISM250	$385.45 Billion	0.41%	#101 of 250

Weight: Alembic Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Alembic Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Alembic Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.03x

Alembic Pharmaceuticals Limited's market cap is 0.03 times its annual revenue

Industry average: 0.53x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.31x

Alembic Pharmaceuticals Limited's market cap is 0.31 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.16 Billion	$31.23 Billion	$7.20 Billion	0.04x	0.16x
2017	$1.05 Billion	$31.05 Billion	$4.03 Billion	0.03x	0.26x
2018	$1.19 Billion	$31.30 Billion	$4.13 Billion	0.04x	0.29x
2019	$1.15 Billion	$39.35 Billion	$5.84 Billion	0.03x	0.20x
2020	$2.09 Billion	$46.06 Billion	$8.29 Billion	0.05x	0.25x
2021	$1.64 Billion	$53.93 Billion	$11.46 Billion	0.03x	0.14x
2022	$1.19 Billion	$53.06 Billion	$5.21 Billion	0.02x	0.23x
2023	$1.60 Billion	$56.53 Billion	$3.42 Billion	0.03x	0.47x
2024	$2.27 Billion	$62.29 Billion	$6.16 Billion	0.04x	0.37x
2025	$1.80 Billion	$66.72 Billion	$5.83 Billion	0.03x	0.31x

Competitor Companies of APLLTD by Market Capitalization

Companies near Alembic Pharmaceuticals Limited in the global market cap rankings as of June 18, 2026.

Key companies related to Alembic Pharmaceuticals Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#513	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#561	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$43.22
#624	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$44.20 Billion	CN¥47.35
#635	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.60

Alembic Pharmaceuticals Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Alembic Pharmaceuticals Limited's market cap moved from $1.35 Billion to $ 1.59 Billion, with a yearly change of 1.19%.

Year	Market Cap	Change (%)
2026	Rs1.59 Billion	-11.87%
2025	Rs1.80 Billion	-20.64%
2024	Rs2.27 Billion	+41.99%
2023	Rs1.60 Billion	+34.02%
2022	Rs1.19 Billion	-27.46%
2021	Rs1.64 Billion	-21.29%
2020	Rs2.09 Billion	+81.90%
2019	Rs1.15 Billion	-3.73%
2018	Rs1.19 Billion	+13.90%
2017	Rs1.05 Billion	-10.14%
2016	Rs1.16 Billion	-13.91%
2015	Rs1.35 Billion	--

End of Day Market Cap According to Different Sources

On Jun 17th, 2026 the market cap of Alembic Pharmaceuticals Limited was reported to be:

Source	Market Cap
Yahoo Finance	$1.59 Billion USD
MoneyControl	$1.59 Billion USD
MarketWatch	$1.59 Billion USD
marketcap.company	$1.59 Billion USD
Reuters	$1.59 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic

Market Cap

$1.59 Billion

Rs146.58 Billion INR

Market Cap Rank

#7157 Global

#333 in India

Share Price

Rs745.70

Change (1 day)

+1.08%

52-Week Range

Rs646.55 - Rs1039.10

All Time High

Rs1247.70